Editorial Policies

Editorial Scope

The Journal of Hematology Oncology Pharmacy (the Journal) follows the recommendations of the International Committee of Medical Journal Editor’s (ICMJE) uniform requirements and the Principles of Transparency and Best Practices in Scholarly Publishing, a joint statement released by the Committee on Publication Ethics (COPE), the Directory of Open Access Journals (DOAJ), the World Association of Medical Editors (WAME), and the Open Access Scholarly Publishing Association (OASPA) for manuscript preparation, review, editing, and publication. The full ICMJE recommendations can be accessed at www.icmje.org/urm_main.html, and the complete joint statement by COPE, DOAJ, COPE, WAME, and OASPA is located at https://doaj.org/apply/transparency/.

The Journal of Hematology Oncology Pharmacy is an independent, peer-reviewed journal founded in 2011 to provide hematology and oncology pharmacy practitioners and other healthcare professionals with high-quality peer-reviewed information relevant to hematologic and oncologic conditions to help them optimize drug therapy for patients.

All articles include an Author Disclosure Statement with potential conflicts of interest and a Funding Source statement if the article/study was funded by an outside entity. The editors retain complete authority over the editorial process of all articles published in the Journal.

All articles submitted to the Journal are assigned 2 or 3 peer reviewers by the relevant section editor, according to the expertise evident in the article and the professional and scientific expertise of the reviewers. The Journal of Hematology Oncology Pharmacy implements a double-anonymized model where the peer reviewers’ identities are not made visible to the authors, and the authors’ identities are not made visible to the peer reviewers. The authors’ identities are visible to the section editors, and the section editors’ identities are visible to the authors, however.

Once accepted, all articles are edited for style, sense, and readability; in addition, all data and facts cited are verified.

Articles that are accepted for publication are scheduled by the Journal editors for a quick and timely publication within 1 to 3 months.

Editorial Freedom

The co-editors-in-chief and the section editors have full authority over the editorial content published in the Journal. No outside intervention, such as personal relationships/agendas and commercial considerations, can directly or indirectly influence the selection, evaluation, and scheduling of individual articles. The decision to publish an article depends entirely on the merit of the information and its relevance to the Journal’s editorial objectives and may not in any way involve commercial or financial considerations.

The Journal's editorial board and other experts serving as peer reviewers have full independence in the peer-review process and in their recommendations for accepting or rejecting an article, as well as the type of comments they provide. Article reviews are done in a double-anonymized fashion: all author information is masked to the peer reviewers and the peer reviewers’ information is masked to authors. The authors’ identities are visible to the section editors, and the section editors’ identities are visible to the authors, however.

Any funding source for the article is provided to reviewers.

Appealing an Editorial Decision

The Journal’s co-editor’s-in-chief will consider an appeal from authors. Together with the relevant section editor involved in the original review, they will carefully reassess the submitted article plus any revisions that the authors have instituted in response to the rejection.

Letters to the Editor

Readers are encouraged to submit comments or critiques of any article. All relevant comments are published in the print journal and online, and authors are asked to respond to such comments. Please send all correspondence regarding published articles to editorial@JHOPonline.com.

Corrections

If correction to a published article is needed, the Journal issues the correction as soon as possible, detailing the changes from the original version and listing the correction in the Table of Contents for the next print issue. In addition, the article is corrected in the online version with details of the changes from the original version and the date that the changes were made. Please send all correspondence regarding published articles to editorial@JHOPonline.com.

Confidentiality

The information contained within a submitted article is strictly confidential and cannot be discussed with anyone other than the authors.

The manuscript review process is confidential and cannot be shared with anyone who is not directly involved in that process. The Journal staff, section editors, and peer reviewers may not share any information regarding the submission of an article, or any aspect of the article, before publication. Thus, the peer-review process is conducted with full confidentiality: peer reviewers and the section editors may not discuss the submitted article or its topic or the review with anyone other than the Journal staff and the editors involved in the peer-review process for that article.

Authorship

The Journal of Hematology Oncology Pharmacy adheres to the ICMJE authorship criteria. All authors must meet the 4 criteria outlined by the ICMJE for authorship, which are available at www.icmje.org. It is the responsibility of the authors to decide who can be listed as an author based on those 4 criteria. Contributors who do not meet all 4 criteria should be acknowledged for their contribution in a separate statement. See Author Guidelines for complete details of submitting a manuscript and the requirements for adhering to publishing policies.

It is the responsibility of the authors to disclose both during the submission process and within the submitted work in the appropriate section, if applicable, whether they used artificial intelligence–assisted technologies in the preparation of the submitted article. For example, if artificial intelligence was used for data collection, analysis, or figure generation, authors should disclose this during the submission process and describe this use in the methods section of their article.

The corresponding author must be available to communicate with the editors during the entire submission, peer-review, and manuscript preparation/publication process, as well as be prepared to respond to any potential critiques or requests after the publication of the article.

It is the responsibility of the authors to ensure the independence of the content and to make sure that any funding entity did not influence the content of the article or the interpretation of the results.

Manuscript Preparation

See Author Guidlines for details regarding manuscript preparation, requirements, and procedures. When submitting the article, please go to our online submission portal.

Conflict of Interest

Conflict of interest involves real or potential financial or other personal considerations related to authors or reviewers that may compromise or bias the professional judgment and objectivity of authors or reviewers. The Journal requires all authors to individually complete and sign a Disclosure Form (see Author Guidelines) and declare any real or potential conflicts of interest relevant to the work under consideration that may interfere with the interpretation of the work, to avoid the potential for bias. An Author Disclosure Statement appears at the end of each published article.

The authors are responsible for ensuring that any funding entity did not influence the content of the article or the interpretation of the results. A Funding Source statement will appear at the end of the article if the article/study was funded by an outside entity.

Peer reviewers are asked about potential or real conflicts when invited to critique an article and must excuse themselves from the review of the article if present.

Section editors, who make final decisions about manuscripts, are also asked about potential or real conflicts when presented with a new submission. These editors must recuse themselves from editorial decisions related to such articles.

Other editorial staff members who participate in editorial decisions must also recuse themselves from any decisions in which an article includes interests that pose a potential conflict.

Informed Consent

Identifying personal information, such as patients’ names, initials, or hospital numbers, should not be included in the submitted article, unless the information is essential for the accuracy of the article and the patient (or parent or guardian) has given written informed consent to publish that information. In this case, the patient must be shown the manuscript and the way the information is being used. Authors should provide a signed informed consent when submitting the article and remove any identifying details that are not essential for the purpose of the article.

Authors should obtain informed consent if there is any doubt about the complete anonymity of the information. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors and editors must make sure that the alterations do not distort the scientific meaning.

Human and Animal Rights

When reporting experiments on human subjects, the authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 and 2008. When in doubt, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. When reporting experiments on animals, the authors should indicate whether the institutional and national guide for the care and use of laboratory animals was followed.